Suppliers / Pfizer Italia

Pfizer Italia

Italy 2 duplicate records merged Updated 9 July 2026

Pfizer Italia is a finished-dose manufacturer based in Italy. It appears in 556 regulatory filings across 7 regulators, without an active US DMF or CEP on file. Its filings concentrate with AIFA (IT), EMA and INVIMA (CO). Its GMP standing is certified by ANVISA (Brazil), EMA and EAEU_EEC. Its most recent recorded inspection, by US FDA, closed on 30 September 2022 as VAI.

0
active US DMFs
0
valid CEPs
4
registered plants 1 with an FDA FEI number
556
filings across 7 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
4 of 4 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 30 September 2022 VAI US FDA
  • 9 February 2018 VAI US FDA
  • 22 January 2013 NAI US FDA
  • 11 November 2010 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Ascoli Piceno (AP), United Arab Emirates Not on file
Ascoli Piceno (AP), United Arab Emirates Not on file
ASCOLI PICENO, Italy Not on file
Italy, Italy 3003637173

Filings and GMP by regulator

Regulator Filings GMP certificates
AIFA (IT) 439 None
EMA 76 2
INVIMA (CO) 12 None
ARCSA (EC) 12 None
MINSA (CR) 9 None
DPM (TN) 4 None
ANVISA (Brazil) None 3
EAEU_EEC None 1

Comparing suppliers?

Choose your molecules and target markets. Pfizer Italia comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 30 September 2022.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates